Bahattin Engin Kaya

5PUBLICATIONS
9CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 26, 2026
Prognostic Value of C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index for Survival in Nivolumab-Treated Metastatic Renal Cell Carcinoma.

|May 27, 2026
Prognostic Role of Uric Acid-to-Albumin Ratio in Patients with Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.

|Feb 27, 2026
Prognostic Significance of Albumin-Bilirubin (ALBI) Score in Gastric Cancer Patients Undergoing Curative Resection Followed by Adjuvant Therapy.

Talat Aykut, Oğuzhan Yıldız, Bahattin Engin Kaya

|Jan 28, 2026
Paradoxical Effect of Obesity on Survival Outcomes in Prostate Cancer Patients Receiving Enzalutamide and Abiraterone.

Bahattin Engin Kaya, Mehmet Zahid Koçak, Oğuzhan Yıldız

|Jul 02, 2025
Small cell lung cancer differentiation in patients with driver mutant non-small cell lung cancer: a single center experience.

Oğuzhan Yıldız, Melek Karakurt Eryılmaz, Ali Fuat Gürbüz

Pageof 1

Frequent Collaborators

5 joint publications

Oğuzhan Yıldız

5 joint publications

Talat Aykut

5 joint publications

Murat Araz

5 joint publications

Mehmet Artaç